Appropriate use criteria of left atrial appendage closure devices: latest evidences
暂无分享,去创建一个
G. Casagranda | P. Mazzone | M. Marini | F. Guarracini | S. Branzoli | Marta Martin | A. Coser | S. Quintarelli | R. Bonmassari | Simone Muraglia | Alberto Preda | Eleonora Bonvicini | Marianna Mochen | Marta Martin | A. Preda | S. Muraglia
[1] Rui Chen,et al. Clinical efficacy and safety comparison of Watchman device versus ACP/Amulet device for percutaneous left atrial appendage closure in patients with nonvalvular atrial fibrillation: A study‐level meta‐analysis of clinical trials , 2022, Clinical cardiology.
[2] Ling Li,et al. Percutaneous left atrial appendage closure using the LAmbre device in patients with atrial fibrillation and left atrial appendage thrombus , 2022, Frontiers in Cardiovascular Medicine.
[3] M. Price,et al. Comparative Safety of Transcatheter LAAO With the First-Generation Watchman and Next-Generation Watchman FLX Devices. , 2022, JACC. Cardiovascular interventions.
[4] I. Rashid,et al. Novel cardiac magnetic resonance imaging‐based sizing for left atrial appendage closure , 2022, Journal of cardiovascular electrophysiology.
[5] A. Deshmukh,et al. Cardiac magnetic resonance imaging is a promising modality for left atrial appendage occlusion planning , 2022, Journal of cardiovascular electrophysiology.
[6] J. Saw,et al. Left atrial appendage sealing performance of the Amplatzer Amulet and Watchman FLX device , 2022, Journal of Interventional Cardiac Electrophysiology.
[7] M. Price,et al. Impact of Peridevice Leak on 5-Year Outcomes After Left Atrial Appendage Closure. , 2022, Journal of the American College of Cardiology.
[8] D. Sánchez-Quintana,et al. Anatomy of the left atrial appendage for the interventional cardiologist , 2022, Herzschrittmachertherapie + Elektrophysiologie.
[9] Bin Zhang,et al. Comparison between Amplatzer and Watchman Left Atrial Appendage Closure Devices for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis , 2022, Cardiology.
[10] T. Imamura,et al. Comparison in Short-Term Safety and Efficacy between New-Generation WATCHMAN FLX and Conventional WATCHMAN 2.5 for Percutaneous Left Atrial Appendage Closure , 2022, Journal of clinical medicine.
[11] W. Abusnina,et al. CRT-700.48 Comparative Clinical Outcomes of Left Atrial Appendage Occlusion With WATCHMAN Device Versus Amplatzer Cardiac Plug/Amulet Occluder: A Systematic Review and Meta-Analysis , 2022, JACC: Cardiovascular Interventions.
[12] S. Garcia,et al. In‐hospital outcomes of transesophageal versus intracardiac echocardiography guided left atrial appendage closure , 2022, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[13] G. Condorelli,et al. Left atrial appendage closure with the II generation Ultraseal device: An international registry. The LIGATE study , 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[14] A. Micari,et al. Real‐world experience with the new Watchman FLX device: Data from two high‐volume Sicilian centers. The FLX‐iEST registry , 2022, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[15] OUP accepted manuscript , 2022, Europace.
[16] Christopher R. Ellis,et al. Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion. , 2021, Journal of the American College of Cardiology.
[17] M. Hołda,et al. Morphology of the Left Atrial Appendage: Introduction of a New Simplified Shape-Based Classification System. , 2021, Heart, lung & circulation.
[18] He Huang,et al. Incidence, risk factors, and clinical impact of peridevice leak following left atrial appendage closure with the LAmbre device—Data from a prospective multicenter clinical study , 2020, Journal of cardiovascular electrophysiology.
[19] Jeroen J. Bax,et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). , 2020, European heart journal.
[20] P. Neužil,et al. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation. , 2020, Journal of the American College of Cardiology.
[21] Sumit K. Shah,et al. Meta-Analysis Comparing WatchmanTM and Amplatzer Devices for Stroke Prevention in Atrial Fibrillation , 2020, Frontiers in Cardiovascular Medicine.
[22] A. Natale,et al. Closure of the left atrial appendage using percutaneous transcatheter occlusion devices , 2020, Journal of cardiovascular electrophysiology.
[23] A. Natale,et al. Feasibility of Left Atrial Appendage Occlusion in Left Atrial Appendage Thrombus: A Systematic Review. , 2020, JACC Clinical Electrophysiology.
[24] M. Price,et al. The NCDR Left Atrial Appendage Occlusion Registry. , 2020, Journal of the American College of Cardiology.
[25] J. Saw,et al. Periprocedural Imaging for Left Atrial Appendage Closure: Computed Tomography, Transesophageal Echocardiography, and Intracardiac Echocardiography. , 2020, Cardiac electrophysiology clinics.
[26] J. Brachmann,et al. Late clinical outcomes of lambre versus amplatzer occluders for left atrial appendage closure , 2020, Journal of cardiovascular electrophysiology.
[27] Q. Orlandi,et al. Transesophageal Echocardiography to Diagnose Watchman Device Infection , 2020, CASE.
[28] G. Lippi,et al. Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge , 2020, International journal of stroke : official journal of the International Stroke Society.
[29] D. Delurgio,et al. Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries. , 2019, Journal of the American College of Cardiology.
[30] J. Brachmann,et al. Long‐term clinical outcomes of Amplatzer cardiac plug versus Amulet occluders for left atrial appendage closure , 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[31] A. Khorana,et al. Bleeding incidence and risk factors among cancer patients treated with anticoagulation , 2019, American journal of hematology.
[32] J. Deux,et al. Peridevice Leak After Left Atrial Appendage Closure: Incidence, Risk Factors, and Clinical Impact. , 2019, The Canadian journal of cardiology.
[33] S. Raharjo,et al. Left atrial appendage closure device implantation guided with fluoroscopy only: Long‐term results , 2019, Journal of arrhythmia.
[34] B. Gersh,et al. Risk stratification for stroke in atrial fibrillation: a critique , 2018, European heart journal.
[35] P. Garot,et al. Device-Related Thrombus After Left Atrial Appendage Closure , 2018, Interventional cardiology.
[36] Dhanunjaya R. Lakkireddy,et al. Long term outcomes after left atrial appendage closure with the LARIAT device—Stroke risk reduction over five years follow-up , 2018, PloS one.
[37] M. Alkhouli,et al. Incidence and Clinical Impact of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion: A Meta-Analysis. , 2018, JACC. Clinical electrophysiology.
[38] D. Holmes,et al. Intracardiac Echocardiography in Structural Heart Disease Interventions. , 2018, JACC. Cardiovascular interventions.
[39] E. Pokushalov,et al. Combined atrial fibrillation ablation and left atrial appendage closure: long-term follow-up from a large multicentre registry , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[40] S. Cook,et al. Percutaneous Left Atrial Appendage Closure With the Ultraseal Device: Insights From the Initial Multicenter Experience. , 2018, JACC. Cardiovascular interventions.
[41] C. Tondo,et al. Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion: The LAAO Italian Multicenter Registry. , 2018, JACC. Cardiovascular interventions.
[42] Pascal Defaye,et al. Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation. , 2018, Journal of the American College of Cardiology.
[43] K. Cao,et al. STRUCTURAL : ATRIAL INTERVENTION FOCUS Percutaneous Left Atrial Appendage Closure With the LAmbre Device for Stroke Prevention in Atrial Fibrillation A Prospective , Multicenter Clinical Study , 2022 .
[44] Saibal Kar,et al. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials. , 2017, Journal of the American College of Cardiology.
[45] S. Kische,et al. Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial. , 2017, Heart rhythm.
[46] W. Schillinger,et al. Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Previous Major Gastrointestinal Bleeding (from the Amplatzer Cardiac Plug Multicenter Registry). , 2017, The American journal of cardiology.
[47] K. Kofoed,et al. A comparative study of different imaging modalities for successful percutaneous left atrial appendage closure , 2017, Open Heart.
[48] J. Brachmann,et al. Left Atrial Appendage Closure With the New Occlutech® Device: First in Man Experience and Neurological Outcome , 2017, Journal of cardiovascular electrophysiology.
[49] Thomas Song,et al. Application of 3-Dimensional Computed Tomographic Image Guidance to WATCHMAN Implantation and Impact on Early Operator Learning Curve: Single-Center Experience. , 2016, JACC. Cardiovascular interventions.
[50] G. Lip,et al. EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[51] A. Hobbs,et al. Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: The PREVAIL trial. , 2016, International journal of cardiology.
[52] M. Price,et al. Clinical Implications of Leaks Following Left Atrial Appendage Ligation With the LARIAT Device. , 2016, JACC. Cardiovascular interventions.
[53] Francesca Pistoia,et al. The Epidemiology of Atrial Fibrillation and Stroke. , 2016, Cardiology clinics.
[54] Roshan Prakash,et al. Comparing Measurements of CT Angiography, TEE, and Fluoroscopy of the Left Atrial Appendage for Percutaneous Closure , 2016, Journal of cardiovascular electrophysiology.
[55] B. Meier,et al. Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation. , 2016, International journal of cardiology.
[56] Hyuk-Jae Chang,et al. Predicting Peri-Device Leakage of Left Atrial Appendage Device Closure Using Novel Three-Dimensional Geometric CT Analysis , 2015, Journal of cardiovascular ultrasound.
[57] Randall J. Lee,et al. Percutaneous alternative to the Maze procedure for the treatment of persistent or long-standing persistent atrial fibrillation (aMAZE trial): Rationale and design. , 2015, American heart journal.
[58] P. Mclaughlin,et al. Cardiac CT angiography for device surveillance after endovascular left atrial appendage closure. , 2015, European heart journal cardiovascular Imaging.
[59] S. Willems,et al. Left Atrial Appendage Closure Guided by Integrated Echocardiography and Fluoroscopy Imaging Reduces Radiation Exposure , 2015, PloS one.
[60] Saibal Kar,et al. Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis. , 2015, Journal of the American College of Cardiology.
[61] Saibal Kar,et al. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. , 2014, JAMA.
[62] O. Alfieri,et al. Persistent lone atrial fibrillation: clinicopathologic study of 19 cases. , 2014, Heart rhythm.
[63] Hiroshi Ashikaga,et al. Relationship between left atrial appendage morphology and stroke in patients with atrial fibrillation. , 2013, Heart rhythm.
[64] Petr Neuzil,et al. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). , 2013, Journal of the American College of Cardiology.
[65] Y. Lam. A new left atrial appendage occluder (Lifetech LAmbre Device) for stroke prevention in atrial fibrillation. , 2013, Cardiovascular revascularization medicine : including molecular interventions.
[66] Sanghamitra Mohanty,et al. Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. , 2012, Journal of the American College of Cardiology.
[67] R. Mahajan,et al. Importance of the underlying substrate in determining thrombus location in atrial fibrillation: implications for left atrial appendage closure , 2012, Heart.
[68] G. Lip,et al. Advancing age and bleeding risk are the strongest barriers to anticoagulant prescription in atrial fibrillation. , 2011, Age and ageing.
[69] Gregory Y H Lip,et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. , 2010, Chest.
[70] C. Asher,et al. Comprehensive left atrial appendage optimization of thrombus using surface echocardiography: the CLOTS multicenter pilot trial. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[71] M. Main,et al. Transesophageal echocardiographic diagnosis of left atrial appendage occluder device infection. , 2007, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[72] D. Schwartzman,et al. Dynamic multidimensional imaging of the human left atrial appendage. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[73] Carl van Walraven,et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. , 2002, JAMA.
[74] W. Manning,et al. Accuracy of Transesophageal Echocardiography for Identifying Left Atrial Thrombi: A Prospective, Intraoperative Study , 1995, Annals of Internal Medicine.
[75] G. Lip. Does atrial fibrillation confer a hypercoagulable state? , 1995, The Lancet.
[76] C. Pollick,et al. Assessment of Left Atrial Appendage Function by Transesophageal Echocardiography: Implications for the Development of Thrombus , 1991, Circulation.
[77] A. Weyman,et al. Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. , 1990, Circulation.